PRISM MediaWire

PRISM MarketView

Atara Biotherapeutics Files IND to Advance Lupus Treatment

New York, February 15, 2024 - PRISM MarketView - PRISM MediaWire - Atara Biotherapeutics (Nasdaq: ATRA) has submitted an Investigational New Drug (IND) application to the FDA for the use of ATA3219 as a monotherapy for the treatment of systemic lupus erythematosus(SLE) w...

15 February 2024

PRISM MarketView

Soluna Holdings Dives into AI Hosting with Strategic Co-location Partnership

New York, February 14, 2024 - PRISM MarketView - PRISM MediaWire - Soluna Holdings, Inc. (NASDAQ: SLNH), a pioneer in developing green data centers, has ventured into the AI hosting market through a landmark co-location agreement with a GPU startup specializing in AI com...

14 February 2024

PRISM MarketView

Inspira Technologies’ Stock Jumps Following First U.S. Patent for Blood Oxygenation System

New York, February 14, 2024 - PRISM MarketView - PRISM MediaWire - Inspira Technologies (Nasdaq: IINN), a pioneering medical technology company aiming to advance beyond traditional mechanical ventilators, has been granted the first-ever U.S. Patent for an orbiting blood...

14 February 2024

PRISM MarketView

Biotricity Expecting Record Margins for Q3

New York, February 14, 2024 - PRISM MarketView - PRISM MediaWire - Technology-as-a-Service company, Biotricity (Nasdaq: BTCY) expects to announce record margins and operational efficiency for the third quarter of fiscal year 2024. The company is expecting record gross ma...

14 February 2024

PRISM MarketView

PRISM EV Index Update: Beam Global Expands Federal Presence

New York, February 13, 2024 - PRISM MarketView -PRISM MediaWire -Beam Global (Nasdaq: BEEM), a sustainable infrastructure pioneer for transportation electrification and energy security, has made significant strides by securing first-time orders from six federal entities ...

13 February 2024

PRISM MarketView

PRISM Insight: Cannabis Stocks May Be Seeing Green During Marijuana Awareness Month as Investors Wait on DEA’s Rescheduling Decision

New York, February 13, 2024 - PRISM MarketView - PRISM MediaWire - Cannabis stocks are seeing a resurgence as investors await a decision from the DEA on potentially rescheduling marijuana. The AdvisorShares Pure US Cannabis ETF and other related ETFs have shown significa...

13 February 2024

PRISM MarketView

Adverum Demonstrates “Sustained Disease Control” in Phase 2 Trial for Macular Degeneration

New York, February 13, 2024 - PRISM MarketView - PRISM MediaWire - Adverum Biotechnologies (Nasdaq: ADVM) has reported positive preliminary safety and efficacy data from a Phase 2 trial in patients with wet age-related macular degeneration (AMD) at the 47th Annual Meetin...

13 February 2024

PRISM MarketView

FDA Fast Track for BioXcel’s Prostate Cancer Treatment

New York, February 13, 2024 - PRISM MarketView - PRISM MediaWire - Biopharmaceutical company, BioXcel Therapeutics, Inc. (Nasdaq: BTAI), has been granted FDA Fast Track designation for BXCL701 in combination with a CPI for the treatment of patients with metastatic small...

13 February 2024

PRISM MarketView

The EV Market’s Positive Charge: PRISM Emerging EV Index Sees Green on the Screen

New York, February 13, 2024 - PRISM MarketView - PRISM MediaWire - The electric vehicle (EV) sector showcased its resilience and growth potential on Monday, as reflected in the performance of the PRISM Emerging EV Index. With carmakers steering towards more competitive p...

13 February 2024

PRISM MarketView

Matterport and Visiting Media Partner to Boost Hotel Marketing and Sales

New York, February 09, 2024 - PRISM MarketView - Matterport, Inc.,(Nasdaq: MTTR) a leader in digital twin technology, has established a significant partnership with Visiting Media, a leader in immersive sales enablement for the hospitality sector, to enhance hotel market...

9 February 2024